Spruce Biosciences to Participate in May Investor Conferences
02 Mai 2023 - 10:05PM
Business Wire
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage
biopharmaceutical company focused on developing and commercializing
novel therapies for rare endocrine disorders with significant unmet
medical need, today announced that company management will
participate in two upcoming investor conferences taking place in
May.
- The JMP Securities Life Sciences Conference Date:
May 15-16, 2023 Format: Fireside chat (May 15, 2023 at 1:30
p.m. ET) and 1x1 meetings
- 2023 RBC Capital Markets Global Healthcare Conference
Date: May 16-17, 2023 Format: Fireside chat (May 17,
2023 at 3:05 p.m. ET) and 1x1 meetings
Interested parties can access the webcast for each conference
presentation from the Events section of the company’s investor
relations website at https://investors.sprucebiosciences.com. A
replay of the webcasts will be available after the conclusion of
the live presentations for approximately 30 days.
About Spruce Biosciences
Spruce Biosciences is a late-stage biopharmaceutical company
focused on developing and commercializing novel therapies for rare
endocrine disorders with significant unmet medical need. Spruce is
initially developing its wholly-owned product candidate,
tildacerfont, as the potential first non-steroidal therapy for
patients suffering from classic congenital adrenal hyperplasia
(CAH). Spruce is also developing tildacerfont for women suffering
from polycystic ovary syndrome (PCOS) with primary adrenal androgen
excess. To learn more, visit www.sprucebiosciences.com and follow
us on Twitter @Spruce_Bio, LinkedIn, Facebook and YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230502005399/en/
Media Contact Will Zasadny Evoke Canale (619) 961-8848
will.zasadny@evokecanale.com media@sprucebio.com
Investors Xuan Yang Solebury Strategic Communications
(415) 971-9412 xyang@soleburystrat.com investors@sprucebio.com
Spruce Biosciences (NASDAQ:SPRB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Spruce Biosciences (NASDAQ:SPRB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
